Of relevance, PBMCs from T2D-PDT exhibit a decrease in catalase and overall glutathione redox cycle activity concomitant with enhanced ROS levels despite anti-diabetic treatment. This evidence concerns the gene CAT and type 2 diabetes mellitus.